ArticleClinical and translational science2026

Ubrogepant Plasma and Cerebrospinal Fluid Exposures in Participants With a History of Migraine: Findings From a Phase 1b Open-Label Trial.

Ramesh R Boinpally et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.